Bernstein Liebhard LLP is investigating whether the Board of Directors of HealthSpring, Inc. (“HealthSpring” or the “Company”) (NYSE: HS) breached its fiduciary duty to its shareholders in agreeing to sell HealthSpring to Cigna Corporation.

Under the terms of the agreement, HealthSpring shareholders will receive $55 in cash for each share they own. The investigation is focused on the potential unfairness of the price to HealthSpring shareholders and the process by which the HealthSpring Board of Directors considered and approved the transaction.

If you are interested in discussing your rights as a HealthSpring shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or

Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journal’s “Plaintiffs’ Hot List” in each of the last nine years.